Home RxNorm 1940496 24 HR dapagliflozin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1940496
RxNorm name 24 HR dapagliflozin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet
Display name Dapagliflozin/metFORMIN XR (Oral Pill)
Full name 24 HR dapagliflozin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet
Term type SCD
Status Active
Strength 2.5-1,000 mg
Dose form 24 HR XR Tab
Route Oral Pill
Updated 2026-10-30 15:31:54 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 092017
Active start 092017
Multiple ingredient YES
Branded NO
Ingredients And Strength# Derived Ingredient Concepts# RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join XIGDUO XR DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE AstraZeneca Pharmaceuticals LP ac8a0f7b-9f69-4495-abbc-3a47cd75a859 2026-08-11 Boxed warning, Warnings, Adverse reactions Exact identifier rxcui: 1940496
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective ac8a0f7b-9f69-4495-abbc-3a47cd75a859 dapagliflozin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR dapagliflozin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [SCD] · dapagliflozin 2.5 MG / metformin HCl 1000 MG 24HR Extended Release Oral Tablet [SY] 3 38 These highlights do not include all the information needed to use XIGDUO XR safely and effectively. See full prescribing information for XIGDUO XR. XIGDUO ® XR (dapagliflozin and metformin hydrochloride extended-release) tablets, for oral use Initial U.S. Approval: 2014 20241220
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 2.5 MG / 1000 MG ATTRIBUTES GENERAL_CARDINALITY MULTI ATTRIBUTES HUMAN_DRUG US ATTRIBUTES QUANTITY 24 HR ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 0 CODES VUID 4037223 NAMES Prescribable Synonym dapagliflozin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet NAMES Tallman Synonym 24 HR dapagliflozin 2.5 MG / metFORMIN hydrochloride 1000 MG Extended Release Oral Tablet NAMES Tallman Synonym dapagliflozin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet SOURCES Source Micromedex RED BOOK SOURCES Source Multum MediSource Lexicon SOURCES Source National Drug Data File Plus Source Vocabulary SOURCES Source Veterans Health Administration National Drug File